2026-07-27
Can the Brain Reclaim a Bladder That Won’t Move After Spinal Cord Injury? — What the Anti-RGMa Antibody Elezanumab Showed in Rats
Neurogenic bladder afflicts more than 80% of people with spinal cord injury. A careful reading of a preclinical study reporting that the anti-RGMa antibody elezanumab improved voiding function and neuroplasticity in rats. Efficacy in humans has not yet been shown.
解説を読む →
